innate immunity

Nanjing, China — October 30, 2026 Nanjing Leads Biolabs Co., Ltd. announced that the first patient with systemic lupus...

OCALA, Fla. — September 22, 2026 AIM ImmunoTech Inc. highlighted the potential role of Ampligen® (rintatolimod) in pancreatic cancer...

MELBOURNE, Australia — September 15, 2026 ENA Respiratory announced that the first participants have been dosed in Part B...

LEIDEN, Netherlands — September 9, 2026 Leyden Laboratories B.V. announced positive Phase 1 results for RIG-101, supporting advancement of...

AUSTIN, Texas, August 12, 2026 Natera, Inc. announced a new collaboration with Kupando Therapeutics to support a Phase 1...

October 14, 2025 | Düsseldorf, Germany — Abalos Therapeutics announced the publication of preclinical proof-of-concept data in Cell Reports...